IIL.GSE INTRAVENOUS INFUSIONS LIMITED
Company Analysis
Latest News
🟢 Intravenous Infusions is trading 10% up today, extending a multi-day rally since July 17
Intravenous Infusions is trading 10% up at GHS 0.66, extending a strong rally that has seen consecutive daily gains of approximately 8–10% since July 17,...
🟢 Intravenous Infusions is trading 8.3% up today as CCM Healthcare stake acquisition extends rally
Intravenous Infusions is trading 8.3% up today at GHS 0.39 as a strategic stake acquisition by CCM Healthcare Investments continues to fuel a multi-day...
CCM Healthcare's Million-Share Bet on Intravenous Infusions: Smart Money Signal or a Drop in the Bucket?
Shares of Intravenous Infusions Limited surged as much as 37.5% over five trading sessions on the Ghana Stock Exchange after CCM Healthcare Investments FZCO...
🟢 Intravenous Infusions is trading 10% up today following CCM Healthcare stake acquisition
Intravenous Infusions is trading 10% up at GHS 0.33, extending a multi-session rally following a disclosed stake purchase by CCM Healthcare Investments...
🟢 Intravenous Infusions surges 9.1% today on news of major stake acquisition by CCM Healthcare Investments
• Intravenous Infusions is trading 9.1% up at $0.24, extending a sharp multi-day rally. • The surge follows recent reports that CCM Healthcare Investments FZCO...
🟢 IIL.GSE is trading 10% up today, extending a multi-day rally despite no clear catalyst
IIL.GSE is trading 10% up at $0.22 as it extends a multi-day rally from $0.16 despite a lack of fresh company-specific news or filings. • The gain continues...